GALACTOSE OXIDATION IN THE DESIGN OF IMMUNOGENIC VACCINES

被引:54
作者
ZHENG, B
BRETT, SJ
TITE, JP
LIFELY, MR
BRODIE, TA
RHODES, J
机构
[1] WELLCOME RES LABS,DEPT PHARMACOL,LANGLEY COURT,S EDEN PK RD,BECKENHAM BR3 3BS,KENT,ENGLAND
[2] WELLCOME RES LABS,DEPT CELL BIOL,BECKENHAM BR3 3BS,KENT,ENGLAND
[3] WELLCOME RES LABS,DEPT DRUG SAFETY EVALUAT,BECKENHAM BR3 3BS,KENT,ENGLAND
关键词
D O I
10.1126/science.1598588
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Potent immunological adjuvants are urgently required to complement recombinant and synthetic vaccines. However, it has not been possible to derive new principles for the design of vaccine adjuvants from knowledge of the mechanism of immunogenicity. Carbonyl-amino condensations, which are essential to the inductive interaction between antigen-presenting cells and T helper cells, were tested as a target for the enhancement of immune responses. Enzymic oxidation of cell-surface galactose to increase amine-reactive carbonyl groups on murine lymphocytes and antigen-presenting cells provided a potent, noninflammatory method of enhancing the immunogenicity of viral, bacterial, and protozoal subunit vaccines in mice.
引用
收藏
页码:1560 / 1563
页数:4
相关论文
共 28 条
[1]   THE IMMUNOLOGICAL PRINCIPLES OF VACCINATION [J].
ADA, GL .
LANCET, 1990, 335 (8688) :523-526
[2]   THE INTERACTION BETWEEN PROTEIN-DERIVED IMMUNOGENIC PEPTIDES AND IA [J].
BUUS, S ;
SETTE, A ;
GREY, HM .
IMMUNOLOGICAL REVIEWS, 1987, 98 :115-141
[3]   MOLECULAR-CLONING AND CHARACTERIZATION OF PROTECTIVE OUTER-MEMBRANE PROTEIN-P.69 FROM BORDETELLA-PERTUSSIS [J].
CHARLES, IG ;
DOUGAN, G ;
PICKARD, D ;
CHATFIELD, S ;
SMITH, M ;
NOVOTNY, P ;
MORRISSEY, P ;
FAIRWEATHER, NF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3554-3558
[4]   MODULATION OF IMMUNE-RESPONSE BY A SYNTHETIC ADJUVANT AND ANALOGS [J].
CHEDID, L ;
AUDIBERT, F ;
LEFRANCIER, P ;
CHOAY, J ;
LEDERER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (07) :2472-2475
[5]  
FURUKAWA KS, 1989, J EXP MED, V169, P583
[6]  
GAO XM, 1990, J IMMUNOL, V144, P2883
[7]  
GAO XM, 1991, J IMMUNOL, V147, P3268
[8]  
GAO XM, 1989, J IMMUNOL, V143, P3007
[9]  
GLENNY AT, 1926, CHEM IND JUN, P415
[10]  
GREGORIADIS G, 1989, IMMUNOLOGICAL ADJUVA